Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term finasteride treatment for tics in Tourette syndrome and compulsive pounding in Parkinson's disease
2011-000612-26Phase 2Active
- Sponsor
- Azienda Ospedaliero Universitaria di Cagliari
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of finasteride in Tourette syndrome (TS), Parkinson's disease (PD), obsessive compulsive disorder (OCD) and 1 more, sponsored by Azienda Ospedaliero Universitaria di Cagliari. Primary endpoints: Change in tic severity (YGTSS) and Change in obsessive-compulsive symptoms (YBOCS). Started Mar 2012; status: active.
02
Drugs
finasteride
03
Conditions
Tourette syndrome (TS)Parkinson's disease (PD)obsessive compulsive disorder (OCD)tic disorder
Beyond the preview
Go deeper on 2011-000612-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000612-26.